SCM
KURA icon

Sio Capital Management’s Kura Oncology KURA Stock Holding History

Sio Capital Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-228,318
Closed -$4.28M – 76
2021
Q3 		$4.28M Buy
228,318
+6,055
+3% +$114K 1.36% 22
2021
Q2 		$4.63M Buy
222,263
+8,792
+4% +$218K 1.15% 28
2021
Q1 		$6.04M Buy
213,471
+81,188
+61% +$2.57M 1.23% 28
2020
Q4 		$4.32M Buy
132,283
+101,000
+323% +$3.55M 0.88% 38
2020
Q3 		$959K Sell
31,283
-11,400
-27% -$252K 0.19% 75
2020
Q2 		$696K Buy
+42,683
New +$616K 0.2% 69
2019
Q1 		– Sell
-144,411
Closed -$2.03M – 80
2018
Q4 		$2.03M Sell
144,411
-582,847
-80% -$7.72M 0.74% 47
2018
Q3 		$12.7M Sell
727,258
-110,346
-13% -$2.12M 4.37% 4
2018
Q2 		$15.2M Buy
837,604
+180,193
+27% +$3.05M 8.43% 1
2018
Q1 		$12.3M Buy
657,411
+265,384
+68% +$5.17M 7.41% 3
2017
Q4 		$6M Buy
392,027
+116,296
+42% +$1.71M 3.38% 6
2017
Q3 		$4.12M Buy
+275,731
New +$2.59M 2.14% 14

Other funds holding KURA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return

Sio Capital Management's KURA Position: Q4 2021 in Review

Sio Capital Management sold out of Kura Oncology (KURA) in Q4 2021, closing a stake of 228,318 shares — an estimated $4.28M sold.

Sio Capital Management first reported a position in KURA in Q3 2017 and held it in 12 quarters. The position peaked at $15.2M in Q2 2018. 151 funds tracked by Wall St. Rank hold KURA as of Q4 2021.

  • Sio Capital Management reported no remaining Kura Oncology position as of Q4 2021 after selling out during the quarter.
  • Sio Capital Management sold 228,318 Kura Oncology shares in Q4 2021, an estimated $4.28M.
  • Sio Capital Management first reported a position in Kura Oncology in Q3 2017 and held it in 12 quarters.
  • Sio Capital Management's Kura Oncology position peaked at $15.2M in Q2 2018.
  • 151 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2021.

Based on Sio Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.